Skip to search form
Skip to main content
Skip to account menu
Semantic Scholar
Semantic Scholar's Logo
Search 218,357,097 papers from all fields of science
Search
Sign In
Create Free Account
ocaperidone
Known as:
(2-(4-(6-fluoro-1,2-benzisoxazol-3-yl)-1-piperidinyl)ethyl)-2,9-dimethyl-4H-pyrido(1,2-a)pyrimidin-4-one
, 4H-Pyrido(1,2-a)pyrimidin-4-one, 3-(2-(4-(6-fluoro-1,2-benzisoxazol-3-yl)-1-piperidinyl)ethyl)-2,9-dimethyl-
National Institutes of Health
Create Alert
Alert
Related topics
Related topics
3 relations
Broader (2)
Piperidines
Pyrimidinones
Narrower (1)
R 79598
Papers overview
Semantic Scholar uses AI to extract papers important to this topic.
2001
2001
Agonist, antagonist, and inverse agonist properties of antipsychotics at human recombinant 5-HT(1A) receptors expressed in HeLa cells.
C. Cosi
,
W. Koek
European Journal of Pharmacology
2001
Corpus ID: 24386893
2001
2001
Efficacy of antipsychotic agents at human 5-HT(1A) receptors determined by [3H]WAY100,635 binding affinity ratios: relationship to efficacy for G-protein activation.
A. Newman-Tancredi
,
L. Verrièle
,
M. Touzard
,
M. Millan
European Journal of Pharmacology
2001
Corpus ID: 19319742
2001
2001
Inverse Agonist Properties of Antipsychotic Agents at Cloned, Human (h) Serotonin (5-HT)1B and h5-HT1D Receptors
V. Audinot
,
A. Newman-Tancredi
,
D. Cussac
,
M. Millan
Neuropsychopharmacology
2001
Corpus ID: 34377170
1998
1998
Agonistic properties of alniditan, sumatriptan and dihydroergotamine on human 5‐HT1B and 5‐HT1D receptors expressed in various mammalian cell lines
A. Lesage
,
R. Wouters
,
+5 authors
J. Leysen
British Journal of Pharmacology
1998
Corpus ID: 38918667
Alniditan, a novel migraine abortive agent, is a potent 5‐HT1B/5‐HT1D receptor agonist of nM affinity. We compared the agonistic…
Expand
Highly Cited
1996
Highly Cited
1996
Alniditan, a new 5-hydroxytryptamine1D agonist and migraine-abortive agent: ligand-binding properties of human 5-hydroxytryptamine1D alpha, human 5-hydroxytryptamine1D beta, and calf 5…
J. Leysen
,
W. Gommeren
,
+8 authors
A. Lesage
Molecular Pharmacology
1996
Corpus ID: 10266968
Alniditan is a new migraine-abortive agent. It is a benzopyran derivative and therefore structurally unrelated to sumatriptan and…
Expand
Review
1996
Review
1996
Risperidone and related 5HT2/D2 antagonists: a new type of antipsychotic agent?
A. Megens
,
L. Kennis
Progress in Medicinal Chemistry
1996
Corpus ID: 35863991
Highly Cited
1993
Highly Cited
1993
Activity of serotonin (5-HT) receptor agonists, partial agonists and antagonists at cloned human 5-HT1A receptors that are negatively coupled to adenylate cyclase in permanently transfected HeLa…
P. Pauwels
,
P. van Gompel
,
J. Leysen
Biochemical Pharmacology
1993
Corpus ID: 24506885
Highly Cited
1992
Highly Cited
1992
In vitro and in vivo receptor binding and effects on monoamine turnover in rat brain regions of the novel antipsychotics risperidone and ocaperidone.
J. Leysen
,
P. Janssen
,
W. Gommeren
,
J. Wynants
,
P. Pauwels
,
P. Janssen
Molecular Pharmacology
1992
Corpus ID: 22884698
Risperidone and ocaperidone are new benzisoxazol antipsychotics with particularly beneficial effects in schizophrenia. We report…
Expand
1992
1992
Behavioral disinhibition and depression in amphetaminized rats: a comparison of risperidone, ocaperidone and haloperidol.
A. Megens
,
C. Niemegeers
,
F. Awouters
Journal of Pharmacology and Experimental…
1992
Corpus ID: 25605506
The mixed serotonin-2/dopamine-D2 antagonists risperidone and ocaperidone were compared with the specific D2 antagonist…
Expand
1992
1992
Pharmacological profile of the new potent neuroleptic ocaperidone (R 79,598).
A. Megens
,
F. Awouters
,
T. Meert
,
K. Schellekens
,
C. Niemegeers
,
P. Janssen
Journal of Pharmacology and Experimental…
1992
Corpus ID: 42199096
Ocaperidone, a new benzisoxazolyl piperidine neuroleptic, was compared with haloperidol, risperidone and ritanserin in a large…
Expand
By clicking accept or continuing to use the site, you agree to the terms outlined in our
Privacy Policy
(opens in a new tab)
,
Terms of Service
(opens in a new tab)
, and
Dataset License
(opens in a new tab)
ACCEPT & CONTINUE